banner
New Risk Analysis
Welcome.  Sign in or register.
Refer A Friend | Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1027 U.S. listed China Stocks and Counting...
 Tracking 1320 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearchGeoBargainsGeoSpecialsGuidanceMake GoodsPenny StocksRecent AdditionsAll Companies

 Sinovac Biotech (NASDAQ:SVA)

GeoProfile
    Overview  
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders
Company Description

Sinovac Biotech Ltd. is a leading China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM)(H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine.

Reverse Merger Filing

Web site: http://www.sinovac.com

Last updated April 17, 2008

Home  |   Market Activity  |   Research  |   Message Boards  |   My Account  |   Refer a Friend   |   Contact Us

About  |   Site Map  |   Privacy Policy  |   Terms of Service  |   Twitter  |   © 2009 GeoInvesting LLC


Articles | Asian Stock | Asian Stock Market | Asian Stocks | Business Outlook | Company Analysis | Company Profile
Day Trading | Stock Analysis| Stock Research


Statements and scenarios on GeoInvesting are not intended to be investment advice, but are based on some
commonly used investment guidelines. They are provided to aid investors in making their own investment decisions.
Please review GeoInvesting's complete disclosures and disclaimers under the link above regarding "Terms of Service."